JAMA Otolaryngol Head Neck Surg
Dr. Alireza Mirmiran, MD
- Medicare services, 2024
- 1,350
- Medicare patients, 2024
- 226
- Part D claims, 2024
- 159
- Publications
- 1
- Hospital affiliations
- 3
- Practice address
- 8303 Dodge St, Omaha, NE 68114
- Practice phone
- Call (402) 354-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Nebraska Methodist Hospital
Omaha, Nebraska
Find Dr. Mirmiran's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alireza Mirmiran is a radiation oncologist in Omaha, Nebraska
Dr. Mirmiran practices at Nebraska Methodist Hospital in Omaha, Nebraska.
Dr. Mirmiran's NPI, 1801930441, was assigned on February 16, 2007. Dr. Mirmiran graduated from University of California, San Diego School of Medicine in 2003. Dr. Mirmiran holds Nebraska license 25152.
- NPI
- 1801930441NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6507918182
- NPI enumeration date
- February 16, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (402) 354-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 49
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Alireza Mirmiran practices at Nebraska Methodist Hospital in Omaha, Nebraska
Dr. Mirmiran's primary practice is Nebraska Methodist Hospital, at 8303 Dodge St, Omaha, NE 68114 in Douglas County. The practice phone is (402) 354-4000.
- Nebraska Methodist Hospital8303 Dodge St, Omaha, NE 68114 · Douglas CountyPhone(402) 354-4000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Alireza Mirmiran is affiliated with 4 sites of care and 1 medical group
Dr. Mirmiran's primary practice is Nebraska Methodist Hospital in Omaha, Nebraska. Dr. Mirmiran is also affiliated with Nebraska Medical Center. The medical group on file is Nebraska Methodist Hospital. Dmand AI also links Dr. Mirmiran to 2 more hospitals, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Alireza Mirmiran's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirmiran practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Nebraska Methodist Hospital | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alireza Mirmiran is one of 36 radiation oncologists in Nebraska
Radiation oncology is Dr. Mirmiran's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mirmiran is licensed in Nebraska.
Specialties and state licenses
- Radiation oncology, NebraskaPrimary
Radiation oncologists near Dr. Mirmiran
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alireza Mirmiran billed Medicare for 1,350 services in 2024
CMS data shows 1,350 Medicare services from Dr. Mirmiran across 16 procedure codes in 2024, for 226 Medicare patients. Medicare paid $99,530 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Mirmiran's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 1,0842024: 85921%
- Office and hospital visits
- 2023: 3102024: 3013%
- Other services
- 2023: 02024: 190
Dr. Mirmiran compared with the Nebraska median for radiation oncologists, 2024
- Dr. Mirmiran
- Nebraska median
- Medicare services
- 1,350vs 1,57915% below
- Medicare patients
- 226vs 19516% above
- Part D claims
- 79vs 263.0 times
Medians across 33 radiation oncologists in Nebraska with Dmand AI profiles that report each measure.
Dr. Mirmiran's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mirmiran?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mirmiran and other radiation oncologists in Nebraska.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alireza Mirmiran treated 226 Medicare patients in 2024, average age 75
CMS counts 226 Medicare patients who saw Dr. Mirmiran in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mirmiran's median patient age at 69, with 50% women.
Dr. Mirmiran's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Mirmiran's Medicare patients by sex, 2024
- Women10044%
- Men12656%
Chronic conditions among Dr. Mirmiran's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol73%
- Arthritis48%
- Ischemic heart disease33%
- COPD27%
- Diabetes27%
- Chronic kidney disease22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mirmiran's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women50%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Alireza Mirmiran wrote 159 Medicare Part D claims in 2024
In 2024, Dr. Mirmiran wrote 159 Medicare Part D claims for 53 patients. 89% of them were for generic drugs. CMS names the drug for 79 of them, across 5 drugs with 11 or more claims each, at $856 in total drug cost. In 2023, CMS named 120 claims across 5 drugs.
Dr. Mirmiran's Part D claims by kind of drug, 2024
- Generic142 claims89%
- Brand-name17 claims11%
Dr. Mirmiran's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1202024: 7934%
Drugs named by CMS: 5 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Alireza Mirmiran takes part in Medicare
Dr. Mirmiran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alireza Mirmiran has 1 publication on record
Dmand AI links 1 paper to Dr. Mirmiran. Dr. Mirmiran's most frequent co-authors are Christian Louis Barney, MD, Andrew M. Coughlin, MD and Randall T. Duckert, MD.
Dr. Mirmiran's most frequent co-authors
- Christian Louis Barney, MD1 shared paper
- Andrew M. Coughlin, MD1 shared paper
- Randall T. Duckert, MD1 shared paper
Recent publications by Dr. Mirmiran
See who Dr. Mirmiran researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mirmiran works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alireza Mirmiran received $13,453 in industry payments from 2016 to 2025
CMS Open Payments shows 40 general payments to Dr. Mirmiran from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,134. It also lists 1 research payment totaling $250 in 2016.
General payments to Dr. Mirmiran by program year, 2016 to 2025
General payments to Dr. Mirmiran by kind, 2016 to 2025
- Consulting fees$11,37285%
- Food and beverage$1,1358%
- Speaker and faculty fees$5154%
- Travel and lodging$2312%
- Honoraria$2001%
Companies that paid Dr. Mirmiran the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Alireza Mirmiran graduated from University of California, San Diego School of Medicine
Dr. Mirmiran graduated from University of California, San Diego School of Medicine in 2003.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Alireza Mirmiran's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alireza Mirmiran
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alireza Mirmiran's NPI number?
Dr. Alireza Mirmiran's NPI number is 1801930441. It was assigned on February 16, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Alireza Mirmiran?
Dr. Alireza Mirmiran is a radiation oncologist in Omaha, Nebraska. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Alireza Mirmiran practice?
Dr. Mirmiran practices at 8303 Dodge St, Omaha, NE 68114. Dr. Mirmiran's primary practice is Nebraska Methodist Hospital in Omaha, Nebraska. Dmand AI also links Dr. Mirmiran to 2 hospitals.
What is Dr. Alireza Mirmiran's office phone number?
The practice phone on file for Dr. Mirmiran is (402) 354-4000.
What is Dr. Alireza Mirmiran's medical license number?
Dr. Mirmiran holds Nebraska license 25152.
Which hospitals is Dr. Alireza Mirmiran affiliated with?
Dr. Mirmiran is affiliated with Nebraska Medical Center. Dmand AI links Dr. Mirmiran to 2 more hospitals.
What medical group is Dr. Alireza Mirmiran part of?
Dr. Mirmiran is linked to Nebraska Methodist Hospital.
Does Dr. Alireza Mirmiran accept Medicare?
Yes. CMS data shows Dr. Mirmiran billed Medicare for 1,350 services in 2024, and Dr. Mirmiran accepts Medicare assignment.
How many Medicare patients does Dr. Alireza Mirmiran see?
CMS counts 226 Medicare patients who saw Dr. Mirmiran in 2024, with an average age of 75.
What services does Dr. Alireza Mirmiran bill to Medicare?
In 2024, Dr. Mirmiran's most billed Medicare services were radiation oncology (77427), office visit, established patient (99213) and radiation oncology (77300).
Show 6 more questionsShow fewer questions
Where did Dr. Alireza Mirmiran go to medical school?
Dr. Mirmiran graduated from University of California, San Diego School of Medicine in 2003.
What drugs does Dr. Alireza Mirmiran prescribe most?
In 2024 Medicare Part D data, Dr. Mirmiran's most prescribed drugs by claims were Tamsulosin HCl, Silver Sulfadiazine and Sertraline HCl.
Has Dr. Alireza Mirmiran received payments from drug or device companies?
CMS Open Payments shows $13,453 in general payments to Dr. Mirmiran from 17 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Alireza Mirmiran been practicing?
Dr. Mirmiran graduated from medical school in 2003, 23 years ago.
Does Dr. Alireza Mirmiran do research?
Dmand AI links 1 publication to Dr. Mirmiran.
Who does Dr. Alireza Mirmiran publish with?
Dr. Mirmiran's most frequent co-authors are Christian Louis Barney, MD (1 shared paper), Andrew M. Coughlin, MD (1 shared paper) and Randall T. Duckert, MD (1 shared paper).
Selling to radiation oncology practices?
See radiation oncologists in Nebraska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card